Nav: Home

Scientists find mechanisms to avoid telomere instability found in cancer and aging cells

January 22, 2018

Researchers from Instituto de Medicina Molecular (iMM) João Lobo Antunes have found that a functional component of telomeres called TERRA has to constantly be kept in check to prevent telomeric and chromosomal instability, one of the underlying anomalies associated with cancer.

Telomeres, the very ends of linear chromosomes such as the ones in humans, protect the stability of genomes by preventing erosion of genetic material and fusion of independent chromosomes. When telomeres are dysfunctional, severe genomic instability arises and features of dysfunctional telomeres are often observed in cancer cells as well as in aged cells, for example from old individuals.

Scientists have tried to understand how telomeres are maintained to better understand the biology of cancer and aging. In this study, the team led by Claus Azzalin wanted to understand whether TERRA could become dangerous if not properly maintained in cells.

Using an extensive combination of molecular biology, cellular biology, high-end microscopy and biochemistry, they found a new interplay between three key telomeric molecules - the long noncoding RNA TERRA and two telomeric proteins, TRF1 and TRF2. While TRF2 is able to promote the formation of RNA: DNA hybrids between TERRA and telomeric DNA, TRF1 prevents this TRF2 associated activity. When this interplay is compromised the ensuing RNA: DNA hybrid structures lead to loss of telomeres and therefore genome instability.

These results show that telomeres in general and, more specifically TERRA, need to be constantly regulated to serve their protective functions. Indeed, a lack of such fine regulation leads to severe telomere (and chromosomal) instability commonly found in cancer and aging cells.

"I'm excited at the idea that our work could illuminate novel avenues for therapeutic intervention based on modulation of RNA in cells" said Claus Azzalin.

These discoveries could help understand the molecular basis of chromosomal instabilities associated with cancer development and age-associated diseases possibly paving the way for new therapeutic approaches.

"I expect this study will open a new window on our understanding of genome stability and ultimately help in the development of aging and cancer therapies" said the study's first author Yong Woo Lee.
-end-


Instituto de Medicina Molecular

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.